Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and TAK-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and Crohn's disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Finch Therapeutics Group Inc..
Finch Therapeutics Group Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Finch Therapeutics Group Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Finch Therapeutics Group Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Finch Therapeutics Group Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Finch Therapeutics Group Inc. and all latest updates of the company are provided.
The 2025 version of Finch Therapeutics Group Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Finch Therapeutics Group Inc.- Key Facts
2.2 Finch Therapeutics Group Inc.- Geographic Locations
2.3 Finch Therapeutics Group Inc.- Subsidiaries and Affiliates
2.4 Finch Therapeutics Group Inc.- Business Divisions
2.5 Finch Therapeutics Group Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Finch Therapeutics Group Inc. Strategic Analysis Review
3.1 Finch Therapeutics Group Inc.- Key Strategies
3.2 Finch Therapeutics Group Inc.- Company Outlook Statement
3.3 Finch Therapeutics Group Inc.- SWOT Analysis
3.3.1 Finch Therapeutics Group Inc.- Key Strengths
3.3.2 Finch Therapeutics Group Inc.- Key Weaknesses
3.3.3 Finch Therapeutics Group Inc.- Potential Opportunities
3.3.4 Finch Therapeutics Group Inc.- Potential Threats
3.4 Finch Therapeutics Group Inc.- Key Competitors
4. Business Description of the Company
4.1 Finch Therapeutics Group Inc.- Business Overview
4.2 Finch Therapeutics Group Inc.- Operations by Segment
5 Products and Services Details
5.1 Finch Therapeutics Group Inc.- Key Products
5.2 Finch Therapeutics Group Inc.- Key Service Areas
5.3 Finch Therapeutics Group Inc.- Key Brands
6 Company Developments
6.1 Finch Therapeutics Group Inc.- Company History
6.2 Finch Therapeutics Group Inc.- Latest Developments
7 Financial Analysis
7.1 Finch Therapeutics Group Inc.- Income Statements
7.2 Finch Therapeutics Group Inc.- Balance Sheet
7.3 Finch Therapeutics Group Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Finch Therapeutics Group Inc.- Direct Competitors
8.2 Finch Therapeutics Group Inc.- Competitor Financial Ratios comparison
8.3 Finch Therapeutics Group Inc.- Competitor Stock Charts Comparison
8.4 Finch Therapeutics Group Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
